Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Millendo Therapeutics Inc (MLND)

Millendo Therapeutics Inc (MLND)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Millendo Therapeutics Inc 110 MILLER AVENUE SUITE 100 ANN ARBOR MI 48104 USA

P: 734-845-9000

Description:

Millendo Therapeutics Inc. is a biopharmaceutical company. It focuses on developing novel treatments for orphan endocrine diseases. The company's product candidate consists of AZP-531 and ATR-101 which are in clinical stage. Millendo Therapeutics Inc., formerly known as OvaScience Inc., is based in Ann Arbor, United States.

Key Statistics

Overview:

Market Capitalization, $K 20,186
Shares Outstanding, K 19,043
Annual Sales, $ 0 K
Annual Net Income, $ -36,410 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -8,390 K
60-Month Beta 0.48
% of Insider Shareholders 3.70%
% of Institutional Shareholders 37.32%
Float, K 18,338
% Float 96.30%

Growth:

1-Year Return -43.01%
3-Year Return -92.23%
5-Year Return -98.73%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 07/02/21
Earnings Per Share ttm -0.90
EPS Growth vs. Prev Qtr 39.29%
EPS Growth vs. Prev Year 60.92%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 06/28/21

MLND Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -91.03%
Return-on-Assets % -72.45%
Profit Margin % 0.00
Net Margin % N/A
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.79
Book Value/Share 1.35
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar